Funding
← Back to your selection

IQ Capital

Activity from announced rounds

Activity in this selectionEurope · Seed
Rounds participated in
2
Confirmed lead rounds
1
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$24.7M
2 disclosed · full round size, not this investor’s share

By stage

Seed2

By primary sector

Biotech2

By country

United Kingdom2

Rounds

2 in this selection
Undecimal Bio

Undecimal Bio develops delivery molecules that help RNA medicines reach specific tissues, with initial research programmes in kidney and vascular disease.

$18MSeed
Lead
Imperagen

Uses quantum physics simulation and AI to engineer high-performance enzymes for pharma and industrial markets

£5MSeed
Role not disclosed